Purchase Order 75N95023P00652
Award Date 9/1/23
Potential Completion Date 8/31/24
Potential Value $23K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lawrence, KS 66047, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute on Drug Abuse awarded a purchase order to the University of Kansas Center for Research Inc. for $22,400.00 on February 18, 2022, to manufacture and supply non-GMP tablet dosage forms of CD206 compound NCGC72 for use in dog sarcoma studies. Work is performed in Lawrence, Kansas. The order carries a firm fixed-price structure with an ultimate completion date of February 17, 2023. No set-aside was used.</p>
- The National Institute on Drug Abuse issued a $1,838,614.86 delivery order to Altasciences Clinical Kansas Inc. on September 25, 2023, for pharmacokinetic and pharmacodynamic trials supporting Phase 1 cocaine drug interaction studies in medication development for substance use disorders. The order runs through October 22, 2025. Place of performance is Shawnee Mission, Kansas. The delivery order is priced on a firm fixed-price basis and was issued under a $21 million single-award indefinite...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed-price purchase order valued at $19,500 to the University of Kansas Center for Research, Inc. to conduct abbreviated testing for the feasibility of developing a solid dosage form for Metarrestin. The solicitation requested the vendor modify existing potency and impurity assays, evaluate physicochemical properties, conduct feasibility studies for...
- This $23,800.00 firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian federal agency, to the University of Kansas Center for Research Inc. on September 12, 2024. The contract is for preliminary solid dosage form development strategy of an ALDH1A1 inhibitor drug candidate for NCATS' Extramural Research and Training Branch (ETB). This contract does not have a set-aside designation. The University of Kansas Center for Research...
- The University of Kansas Center for Research, Inc. was awarded a $38,500 firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide formulation strategy and preclinical support services for a lead compound. Per the solicitation, the contractor will develop a formulation strategy, support preclinical studies, support IND-enabling studies, and submit evidence of its capabilities and a price proposal. The purpose is to...
- This firm fixed-price purchase order for $22,500 was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to the University of Kansas Center for Research Inc. to conduct feasibility testing for solid dosage form strategy options for GPR110 agonist A8. The prime contractor will perform spray drying and adsorption techniques to generate powders from drug-polymer mixtures, emulsions, and suspensions with various...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $10,465 firm fixed price purchase order to Cambrex High Point, Inc. to support retesting of the GLWL-01 reference standard and project specific funding. Cambrex will perform the work in Baltimore, Maryland over a one year period from July 2023 through July 2024. The National Institute on Drug Abuse conducts important biomedical research on drug abuse and addiction to improve...
- The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a $10,000.00 labor-hour purchase order contract to Christoph Kahl, a small business located in Thousand Oaks, California. The contract is for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services to support NIDA's drug discovery and development programs, including the NIH Blueprint Neurotherapeutics, Help End Addiction Longterm...
- This federal contract award is a delivery order under a larger contract vehicle, with Research Triangle Institute (RTI) International as the prime contractor. The contract is with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The award, valued at $376,358.00, is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 16, 2024 to June 15, 2025, with a total period of...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $43,061.60 firm fixed price purchase order to Med Associates, Inc. for self-administration chambers to support research into brain mechanisms of compulsive drug use. Per the original solicitation, the Neuroimaging Research Branch requires additional self-administration training apparatuses for laboratory rats to self-administer compounds like methamphetamine while applying...